​

Funding Round

Series B - Oncorus

Series B - Oncorus

Investment Firm

Overview

Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.

Announced Date

Aug 21, 2019

Closed on Date

Aug 21, 2019

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Perceptive Advisors

Perceptive Advisors

Perceptive Advisors is a debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

9

Investor Name
Participant InvestorAstellas Venture Management
Participant InvestorMPM Capital
Participant InvestorCelgene
Participant InvestorDeerfield
Participant InvestorShinhan Private Equity

Round Details and Background

Oncorus raised $79500000 on 2019-08-21 in Series B

Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 12, 2021
Post-IPO Equity - Oncorus
-57.0M
Apr 05, 2022
Post-IPO Debt - Oncorus
1-20.0M
Dec 16, 2016
Series A - Oncorus
1-5.0M
Jul 19, 2016
Series A - Oncorus
7-57.0M

Recent Activity

There is no recent news or activity for this profile.